A DIGITAL HEALTH INFORMATION JOURNEY
for active personal health management and adherence to treatment”
The Gravitate Health is a public – private partnership with 39 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI2 Associated Partners.
Lorem Ipsum proin gravida nibh vel velit auctor aliquet. Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequatm proin gravida nibh vel ipsum, nec sagittis sem nibh id elit. Duis sed odio sit amet nibh vulputate cursus a sit amet mauris. Morbi accumsan ipsum velit. Nam nec tellus a odio tincidunt auctor a ornare odio. Sed non mauris vitae erat consequat.
Our mission is to equip and empower patients with digital health information and tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life.
This collaboration between academia, industry and stakeholder associations promises strong and unique results and an exciting opportunity to deliver new digital information approaches demonstrated to offer wide benefit to patients.
...Gravitate Health is an integrated digital health information project.
39 partners from all over Europe and the US participate in the project.
![The European Institute for Innovation through Health Data [i-HD]](https://www.gravitatehealth.eu/wp-content/uploads/2021/02/innovation-for-HealthData-thegem-portfolio-justified.jpg)
Meet the project’s Steering Committee members…
AIMS to develop
AIMS to promote
will deliver
an open source digital platform supporting G-Lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization.
Participate in our surveys for consumers / patients / HCPs…
You are welcome to contact us for any matter,
just submit the following form.
Supported by a grant from IMI
The project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945334. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations [EFPIA]. The total budget is 18.5M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects Project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.